Tao Ren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tao Ren has a total of 186 co-authors. Here are the top co-authors by number of shared publications:
Qiuyan Lin
29 shared publicationsBin Xiang
Key Laboratory of Zoonosis Prevention and Control of Guangdong Province, College of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China
25 shared publications- Libin Chen
College of Veterinary Medicine, South China Agricultural University
20 shared publications Ming Liao
Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou, China
16 shared publicationsLibin Chen
College of Veterinary Medicine, South China Agricultural University, Guangzhou, China
15 shared publicationsPei Gao
Key Laboratory of Zoonosis Prevention and Control of Guangdong Province, College of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China
14 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by American Society for Microbiology in Microbiology Spectrum
Lactate accumulation triggered by RNA virus infection facilitates viral replication
As the terminal product of glycolysis, lactate has emerged as a crucial signaling molecule mediating metabolic reprogramming with immune regulation. Although RNA viruses are known to exploit host metabolism, the precise role of lactate accumulation in viral pathogenesis remains to be fully elucidated. Using Newcastle disease virus and influenza A virus as model pathogens, this study demonstrates that RNA virus infection rapidly activates host glycolysis and induces sustained lactate accumulation, thereby creating a microenvironment favorable for viral replication. Pharmacological inhibition of glycolysis markedly suppressed viral proliferation. In inhibition-rescue experiments, exogenous lactate supplementation reversed the antiviral immune gene and IRF3-phosphorylation changes induced by glycolytic inhibition. Adding exogenous sodium lactate without inhibiting glycolysis further repressed antiviral immune gene expression and IRF3 phosphorylation. Mechanistically, virus-induced lactate accumulation was associated with suppression of the retinoic acid-inducible gene I (RIG-I)-like receptor signaling pathway: excess lactate acted upstream of interferon regulatory factor 3 (IRF3), in a manner consistent with inhibition of the mitochondrial antiviral signaling protein (MAVS)-IRF3 axis, thereby attenuating type I interferon production. Together, these findings define a positive feedback loop in which RNA viruses exploit host metabolic reprogramming to accumulate lactate, which in turn restrains antiviral innate immunity and favors viral replication. IMPORTANCE: RNA viruses have no metabolism of their own and must rewire the host cell to replicate. Here, using two viruses from different families—Newcastle disease virus and influenza A virus—we show that infection rapidly drives host glucose uptake and glycolysis and causes lactate to accumulate. Lactate is not an inert by-product: blocking glycolysis lowers lactate, derepresses type I interferon and interferon-stimulated gene expression, and restricts viral replication, while adding lactate back reverses immune-signaling changes induced by glycolytic inhibition and further suppresses interferon regulatory factor 3 (IRF3) phosphorylation. Lactate therefore functions as an immunomodulatory effector linking virus-driven metabolic reprogramming to weakened innate immunity, consistent with inhibition of the mitochondrial antiviral signaling protein (MAVS)-IRF3 axis, forming a positive feedback loop that favoring replication. Since this loop was observed in two distinct RNA viruses, glycolysis and lactate handling may represent host-directed targets for antiviral intervention, while lactate’s broader clinical relevance as an immune biomarker requires further investigation.
- 2 November 2026
- Published by American Society for Microbiology in Microbiology Spectrum
Open AccessLactate accumulation triggered by RNA virus infection facilitates viral replication
As the terminal product of glycolysis, lactate has emerged as a crucial signaling molecule mediating metabolic reprogramming with immune regulation. Although RNA viruses are known to exploit host metabolism, the precise role of lactate accumulation in viral pathogenesis remains to be fully elucidated. Using Newcastle disease virus and influenza A virus as model pathogens, this study demonstrates that RNA virus infection rapidly activates host glycolysis and induces sustained lactate accumulation, thereby creating a microenvironment favorable for viral replication. Pharmacological inhibition of glycolysis markedly suppressed viral proliferation. In inhibition-rescue experiments, exogenous lactate supplementation reversed the antiviral immune gene and IRF3-phosphorylation changes induced by glycolytic inhibition. Adding exogenous sodium lactate without inhibiting glycolysis further repressed antiviral immune gene expression and IRF3 phosphorylation. Mechanistically, virus-induced lactate accumulation was associated with suppression of the retinoic acid-inducible gene I (RIG-I)-like receptor signaling pathway: excess lactate acted upstream of interferon regulatory factor 3 (IRF3), in a manner consistent with inhibition of the mitochondrial antiviral signaling protein (MAVS)-IRF3 axis, thereby attenuating type I interferon production. Together, these findings define a positive feedback loop in which RNA viruses exploit host metabolic reprogramming to accumulate lactate, which in turn restrains antiviral innate immunity and favors viral replication. IMPORTANCE: RNA viruses have no metabolism of their own and must rewire the host cell to replicate. Here, using two viruses from different families—Newcastle disease virus and influenza A virus—we show that infection rapidly drives host glucose uptake and glycolysis and causes lactate to accumulate. Lactate is not an inert by-product: blocking glycolysis lowers lactate, derepresses type I interferon and interferon-stimulated gene expression, and restricts viral replication, while adding lactate back reverses immune-signaling changes induced by glycolytic inhibition and further suppresses interferon regulatory factor 3 (IRF3) phosphorylation. Lactate therefore functions as an immunomodulatory effector linking virus-driven metabolic reprogramming to weakened innate immunity, consistent with inhibition of the mitochondrial antiviral signaling protein (MAVS)-IRF3 axis, forming a positive feedback loop that favoring replication. Since this loop was observed in two distinct RNA viruses, glycolysis and lactate handling may represent host-directed targets for antiviral intervention, while lactate’s broader clinical relevance as an immune biomarker requires further investigation.
- Open Access
- 29 October 2026
- Published by Springer Nature in Cell Communication and Signaling
Sialic acid functions as a primary attachment factor for avian coronavirus and initiates macropinocytosis-mediated viral entry
- 29 October 2026
- Published by Springer Nature in Cell Communication and Signaling
Open AccessSialic acid functions as a primary attachment factor for avian coronavirus and initiates macropinocytosis-mediated viral entry
- Open Access
- 22 September 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (9)
CircRNA0857 acts as an miRNA sponge to promote Newcastle disease virus replication via modulating autophagy
Circular RNAs (circRNAs) are a class of endogenous non-coding RNAs widely expressed across diverse organisms. These molecules are involved in various biological processes, such as transcriptional and post-transcriptional regulation, protein scaffolding, and acting as miRNA sponges. Newcastle disease virus (NDV) replicates and proliferates in a variety of cells, inducing severe organelle stress damage, autophagy, and even cell death. Previous studies have reported that NDV hijacks and uses autophagy to promote its replication and proliferation. However, the involvement and regulatory mechanisms of circRNAs in this process remain largely unexplored. The present study aimed to identify novel circRNAs that modulate NDV replication through autophagy and elucidate their underlying mechanisms. Our findings revealed that circRNA0857 was significantly upregulated in NDV-infected cells. Functional assays showed that silencing circRNA0857 markedly inhibited NDV replication, while its overexpression enhanced viral replication. Mechanistic analyses demonstrated that circRNA0857 functions as a “miRNA sponge,” specifically targeting and sequestering miR1709 and miR1746. These miRNAs were found to regulate the expression of ATG3 and ATG7, respectively, two key autophagy-related genes in the autophagy pathway. By sponging miR1709 and miR1746, circRNA0857 upregulates the expression of ATG3 and ATG7, thereby enhancing autophagy and promoting NDV infection. This study is the first to identify circRNA0857 as a critical regulator in NDV infection, elucidating its role in enhancing NDV-induced autophagy via the miR1709/ATG3 and miR1746/ATG7 signaling axes. These findings significantly advance our understanding of how circRNAs regulate viral infections and provide novel insights into the molecular mechanisms underlying NDV replication. IMPORTANCE: Circular RNAs (circRNAs), as endogenous non-coding RNAs, are widely involved in various biological processes, particularly in the regulatory modulation of miRNA functions. Newcastle disease virus (NDV) can replicate in a variety of cells and promote its proliferation by hijacking and utilizing autophagy. In this study, we screened for novel circular RNAs that regulate NDV replication through modulating host autophagy and identified circRNA0857 as a key regulator of NDV infection. It enhances autophagy and promotes viral replication by acting as a “miRNA sponge,” simultaneously targeting the two signaling axes miR1709/ATG3 and miR1746/ATG7. This research fills a gap in understanding how circRNAs regulate NDV-induced autophagy and provides a new perspective for understanding the interactions between host non-coding RNAs and viruses. This finding deepens our understanding of the pathogenic mechanisms of NDV and offers potential molecular targets for the development of antiviral strategies based on circular RNAs or miRNAs.
- 22 September 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (9)
Open AccessCircRNA0857 acts as an miRNA sponge to promote Newcastle disease virus replication via modulating autophagy
Circular RNAs (circRNAs) are a class of endogenous non-coding RNAs widely expressed across diverse organisms. These molecules are involved in various biological processes, such as transcriptional and post-transcriptional regulation, protein scaffolding, and acting as miRNA sponges. Newcastle disease virus (NDV) replicates and proliferates in a variety of cells, inducing severe organelle stress damage, autophagy, and even cell death. Previous studies have reported that NDV hijacks and uses autophagy to promote its replication and proliferation. However, the involvement and regulatory mechanisms of circRNAs in this process remain largely unexplored. The present study aimed to identify novel circRNAs that modulate NDV replication through autophagy and elucidate their underlying mechanisms. Our findings revealed that circRNA0857 was significantly upregulated in NDV-infected cells. Functional assays showed that silencing circRNA0857 markedly inhibited NDV replication, while its overexpression enhanced viral replication. Mechanistic analyses demonstrated that circRNA0857 functions as a “miRNA sponge,” specifically targeting and sequestering miR1709 and miR1746. These miRNAs were found to regulate the expression of ATG3 and ATG7, respectively, two key autophagy-related genes in the autophagy pathway. By sponging miR1709 and miR1746, circRNA0857 upregulates the expression of ATG3 and ATG7, thereby enhancing autophagy and promoting NDV infection. This study is the first to identify circRNA0857 as a critical regulator in NDV infection, elucidating its role in enhancing NDV-induced autophagy via the miR1709/ATG3 and miR1746/ATG7 signaling axes. These findings significantly advance our understanding of how circRNAs regulate viral infections and provide novel insights into the molecular mechanisms underlying NDV replication. IMPORTANCE: Circular RNAs (circRNAs), as endogenous non-coding RNAs, are widely involved in various biological processes, particularly in the regulatory modulation of miRNA functions. Newcastle disease virus (NDV) can replicate in a variety of cells and promote its proliferation by hijacking and utilizing autophagy. In this study, we screened for novel circular RNAs that regulate NDV replication through modulating host autophagy and identified circRNA0857 as a key regulator of NDV infection. It enhances autophagy and promotes viral replication by acting as a “miRNA sponge,” simultaneously targeting the two signaling axes miR1709/ATG3 and miR1746/ATG7. This research fills a gap in understanding how circRNAs regulate NDV-induced autophagy and provides a new perspective for understanding the interactions between host non-coding RNAs and viruses. This finding deepens our understanding of the pathogenic mechanisms of NDV and offers potential molecular targets for the development of antiviral strategies based on circular RNAs or miRNAs.
- Open Access
- 23 May 2026
- Published by Springer Nature in Veterinary Research
- Vol. 57 (1)
Avian coronaviruses induce inflammatory responses by activating p38/MAPK signaling and NLRP3/caspase-1 inflammasomes through sphingosine-1-phosphate receptor 1
Infectious bronchitis virus (IBV), a member of the γ-coronavirus genus within the Coronaviridae family, is a major pathogenic threat to the global poultry industry. Most IBV infections induce severe renal pathological lesions in chickens, yet the renal metabolic perturbations triggered by IBV infection remain largely elusive. Herein, we applied a metabolomic approach to characterize the metabolic profiles of kidney tissues from IBV-infected specific-pathogen-free (SPF) chickens. IBV infection caused profound alterations in the renal metabolome, encompassing amino acids and their derivatives, energy metabolites, and lipid molecules. Most amino acids and their derivatives were significantly downregulated at 7 days post-infection (dpi), indicating that IBV usurps host amino acid pools to support its own replication in SPF chickens. In addition, the levels of L-glutamine, D-mannose 1-phosphate, and D-galacturonate were markedly elevated post-infection, implying their potential roles in mediating host energy utilization and facilitating viral replication during IBV infection. Subsequently, sphingosine-1-phosphate (S1P)—a key bioactive lipid molecule—was identified as a prominently upregulated metabolite in IBV-infected kidney tissues. Follow-up functional experiments revealed that IBV infection upregulates the S1P-S1PR1 signaling axis, and concomitantly activates the p38/JNK/MAPK pathway as well as the NLRP3/caspase-1 inflammasome. Notably, S1PR1 was found to modulate the p38/MAPK signaling pathway and NLRP3/caspase-1 inflammasome, thereby regulating the expression of the proinflammatory cytokines IL-1β and IL-18. Collectively, our study delineates the comprehensive renal metabolic landscape of chickens in response to IBV infection and identifies S1PR1 as a pivotal regulatory target of IBV-induced renal inflammation. These findings provide novel mechanistic insights for the development of preventive and therapeutic strategies targeting metabolic signaling pathways against IBV infection.
- 23 May 2026
- Published by Springer Nature in Veterinary Research
- Vol. 57 (1)
Open AccessAvian coronaviruses induce inflammatory responses by activating p38/MAPK signaling and NLRP3/caspase-1 inflammasomes through sphingosine-1-phosphate receptor 1
Infectious bronchitis virus (IBV), a member of the γ-coronavirus genus within the Coronaviridae family, is a major pathogenic threat to the global poultry industry. Most IBV infections induce severe renal pathological lesions in chickens, yet the renal metabolic perturbations triggered by IBV infection remain largely elusive. Herein, we applied a metabolomic approach to characterize the metabolic profiles of kidney tissues from IBV-infected specific-pathogen-free (SPF) chickens. IBV infection caused profound alterations in the renal metabolome, encompassing amino acids and their derivatives, energy metabolites, and lipid molecules. Most amino acids and their derivatives were significantly downregulated at 7 days post-infection (dpi), indicating that IBV usurps host amino acid pools to support its own replication in SPF chickens. In addition, the levels of L-glutamine, D-mannose 1-phosphate, and D-galacturonate were markedly elevated post-infection, implying their potential roles in mediating host energy utilization and facilitating viral replication during IBV infection. Subsequently, sphingosine-1-phosphate (S1P)—a key bioactive lipid molecule—was identified as a prominently upregulated metabolite in IBV-infected kidney tissues. Follow-up functional experiments revealed that IBV infection upregulates the S1P-S1PR1 signaling axis, and concomitantly activates the p38/JNK/MAPK pathway as well as the NLRP3/caspase-1 inflammasome. Notably, S1PR1 was found to modulate the p38/MAPK signaling pathway and NLRP3/caspase-1 inflammasome, thereby regulating the expression of the proinflammatory cytokines IL-1β and IL-18. Collectively, our study delineates the comprehensive renal metabolic landscape of chickens in response to IBV infection and identifies S1PR1 as a pivotal regulatory target of IBV-induced renal inflammation. These findings provide novel mechanistic insights for the development of preventive and therapeutic strategies targeting metabolic signaling pathways against IBV infection.
- Open Access
- 16 December 2025
- Published by Springer Nature in Veterinary Research
- Vol. 57 (1)
Newcastle disease virus hijacks chicken red blood cells as dissemination vehicles with concomitant adsorption-mediated cell death
Red blood cells (RBCs) are the most abundant cell type in the blood and play a critical role as the primary carriers of oxygen to tissues and organs through blood circulation. The hemagglutinin-neuraminidase (HN) protein on the surface of the Newcastle disease virus (NDV) contains receptors that bind to the surface of RBCs, endowing NDV with agglutination properties that hold significant clinical diagnostic value. This raises an important question: could NDV bind to RBCs and use their carrier properties to facilitate transport to various tissues and organs? This study conducted both in vivo and in vitro experiments to confirm the adhesion and transport capabilities of chicken RBCs for the Newcastle disease virus. In addition, we found that NDV infection induces apoptosis in RBCs. These findings systematically explored the infection process of NDV in chicken RBCs and its subsequent effects, providing direct evidence of the potential role of chicken RBCs as a transport vehicle for the virus. This research offers a novel perspective on the mechanisms of NDV transmission.
- 16 December 2025
- Published by Springer Nature in Veterinary Research
- Vol. 57 (1)
Open AccessNewcastle disease virus hijacks chicken red blood cells as dissemination vehicles with concomitant adsorption-mediated cell death
Red blood cells (RBCs) are the most abundant cell type in the blood and play a critical role as the primary carriers of oxygen to tissues and organs through blood circulation. The hemagglutinin-neuraminidase (HN) protein on the surface of the Newcastle disease virus (NDV) contains receptors that bind to the surface of RBCs, endowing NDV with agglutination properties that hold significant clinical diagnostic value. This raises an important question: could NDV bind to RBCs and use their carrier properties to facilitate transport to various tissues and organs? This study conducted both in vivo and in vitro experiments to confirm the adhesion and transport capabilities of chicken RBCs for the Newcastle disease virus. In addition, we found that NDV infection induces apoptosis in RBCs. These findings systematically explored the infection process of NDV in chicken RBCs and its subsequent effects, providing direct evidence of the potential role of chicken RBCs as a transport vehicle for the virus. This research offers a novel perspective on the mechanisms of NDV transmission.
- Open Access
- 30 October 2025
- Published by Elsevier in Journal of Infection
- Vol. 91 (6) , 106646
The epidemic pattern of a chikungunya outbreak in China exhibits a three-stage migratory trend
- 30 October 2025
- Published by Elsevier in Journal of Infection
- Vol. 91 (6) , 106646
Open AccessThe epidemic pattern of a chikungunya outbreak in China exhibits a three-stage migratory trend
- Open Access
- 21 September 2025
- Published by Elsevier in Poultry Science
- Vol. 104 (11) , 105865
Genotype-matched recombiant inactivated Newcastle disease virus vaccine confer protection against genotype Ⅻ challenge in geese with maternal antibodies
- 21 September 2025
- Published by Elsevier in Poultry Science
- Vol. 104 (11) , 105865
Open AccessGenotype-matched recombiant inactivated Newcastle disease virus vaccine confer protection against genotype Ⅻ challenge in geese with maternal antibodies
- Open Access
- 30 August 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-26
Lipid nanoparticles-mRNA based on the consensus sequences of avian coronavirus S1 and N genes protect animals against multiple viral infections
Lipid nanoparticles-mRNA play important roles in SARS-CoV-2 infection control. Avian coronavirus infectious bronchitis virus (IBV) comprises eight genotypes with a lack of cross-protection, causing severe economic losses to the poultry industry. Using immunoinformatics methods, five consensus sequence antigens against prevalent IBV strains were designed. Four monovalent lipid nanoparticles-mRNA (GI-19, GI-13, GI-7, GVI-1) and one quadrivalent lipid nanoparticles-mRNA were constructed to develop a broad-spectrum IBV vaccine. The safety and biodistribution of the lipid nanoparticles-mRNA were evaluated in SPF chickens and confirmed that it induced a strong and durable immune response. The lipid nanoparticles-mRNA efficacy in SPF chickens was verified in infection assays with four genotypes of IBV strains, the results showed that immunization with a 10 µg dose provided complete protection for the chickens, while immunization with a 5 µg dose reduced disease severity, organ damage, and mortality, and inhibited viral replication and shedding. Our results indicate that these Lipid nanoparticles-mRNA are immunogenic and protective in preclinical animal models. These data can provide a basis for IBV prevention and control and the development of mRNA vaccines against other prevalent viruses.
- 30 August 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-26
Open AccessLipid nanoparticles-mRNA based on the consensus sequences of avian coronavirus S1 and N genes protect animals against multiple viral infections
Lipid nanoparticles-mRNA play important roles in SARS-CoV-2 infection control. Avian coronavirus infectious bronchitis virus (IBV) comprises eight genotypes with a lack of cross-protection, causing severe economic losses to the poultry industry. Using immunoinformatics methods, five consensus sequence antigens against prevalent IBV strains were designed. Four monovalent lipid nanoparticles-mRNA (GI-19, GI-13, GI-7, GVI-1) and one quadrivalent lipid nanoparticles-mRNA were constructed to develop a broad-spectrum IBV vaccine. The safety and biodistribution of the lipid nanoparticles-mRNA were evaluated in SPF chickens and confirmed that it induced a strong and durable immune response. The lipid nanoparticles-mRNA efficacy in SPF chickens was verified in infection assays with four genotypes of IBV strains, the results showed that immunization with a 10 µg dose provided complete protection for the chickens, while immunization with a 5 µg dose reduced disease severity, organ damage, and mortality, and inhibited viral replication and shedding. Our results indicate that these Lipid nanoparticles-mRNA are immunogenic and protective in preclinical animal models. These data can provide a basis for IBV prevention and control and the development of mRNA vaccines against other prevalent viruses.
- Open Access
- 8 July 2025
- Published by Springer Nature in Veterinary Research
- Vol. 56 (1) , 1-15
Construction of a replication-defective recombinant virus and cell-based vaccine for H9N2 avian influenza virus
The H9N2 subtype of avian influenza is highly contagious, and although it is classified as a low-pathogenic avian influenza virus, its tendency to recombine with other subtypes of avian influenza viruses has made it a potential problem for the poultry industry. Vaccines currently used to prevent this disease are all inactivated, making it difficult to stimulate long-lasting immunity, and have a very weak ability to trigger cellular immunity, thus failing to address the problem of virus shedding. Live-attenuated vaccines are capable of stimulating cellular immunity but carry the risk of recombination with wild-type strains. In this study, we successfully rescued a replication-deficient H9N2 strain (H9-SD18GD12HA) using reverse genetic techniques, which was obtained by replacing the neuraminidase (NA) gene with the open reading frame of the hemagglutinin (HA) gene with the PR8 strain as the backbone. Dynamic growth results showed that H9-SD18GD12HA can proliferate only under NA-containing conditions and therefore cannot grow in normal animals or cells. After immunization of chickens with H9-SD18GD12HA using eye and nose drops, both humoral and cellular immunity were stimulated, and some degree of reduction in virus shedding was observed. These results indicate that H9-SD18GD12HA has good immunogenicity, does not proliferate in vivo, and has the potential to be developed into a novel live-attenuated vaccine for the H9N2 subtype of avian influenza.
- 8 July 2025
- Published by Springer Nature in Veterinary Research
- Vol. 56 (1) , 1-15
Open AccessConstruction of a replication-defective recombinant virus and cell-based vaccine for H9N2 avian influenza virus
The H9N2 subtype of avian influenza is highly contagious, and although it is classified as a low-pathogenic avian influenza virus, its tendency to recombine with other subtypes of avian influenza viruses has made it a potential problem for the poultry industry. Vaccines currently used to prevent this disease are all inactivated, making it difficult to stimulate long-lasting immunity, and have a very weak ability to trigger cellular immunity, thus failing to address the problem of virus shedding. Live-attenuated vaccines are capable of stimulating cellular immunity but carry the risk of recombination with wild-type strains. In this study, we successfully rescued a replication-deficient H9N2 strain (H9-SD18GD12HA) using reverse genetic techniques, which was obtained by replacing the neuraminidase (NA) gene with the open reading frame of the hemagglutinin (HA) gene with the PR8 strain as the backbone. Dynamic growth results showed that H9-SD18GD12HA can proliferate only under NA-containing conditions and therefore cannot grow in normal animals or cells. After immunization of chickens with H9-SD18GD12HA using eye and nose drops, both humoral and cellular immunity were stimulated, and some degree of reduction in virus shedding was observed. These results indicate that H9-SD18GD12HA has good immunogenicity, does not proliferate in vivo, and has the potential to be developed into a novel live-attenuated vaccine for the H9N2 subtype of avian influenza.